Radequinil is a benzodiazepine receptor partial inverse agonist with high affinity for both GABA(-) and GABA(+) ligand binding sites (Kis: 5.15 and 6.11 nM). It is a valuable research tool for investigating GABA_A receptor function in neurological studies, applicable in both in vitro binding assays and in vivo behavioral models.